- Home
- IRT vs PCVX Comparison
IRT vs PCVX Comparison
Compare IRT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IRT | PCVX |
|---|---|---|
| Founded | 2009 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 6.0B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | IRT | PCVX |
|---|---|---|
| Price | $16.53 | $46.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | $21.56 | ★ $101.67 |
| AVG Volume (30 Days) | ★ 2.5M | 1.5M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 4.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $662,924,000.00 | N/A |
| Revenue This Year | $4.19 | N/A |
| Revenue Next Year | $4.72 | N/A |
| P/E Ratio | $181.40 | ★ N/A |
| Revenue Growth | ★ 3.19 | N/A |
| 52 Week Low | $15.07 | $27.66 |
| 52 Week High | $21.89 | $94.60 |
Technical Indicators
Market Signals| Indicator | IRT | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 51.97 |
| Support Level | $16.06 | $43.78 |
| Resistance Level | $17.39 | $48.11 |
| Average True Range (ATR) | 0.31 | 1.99 |
| MACD | -0.01 | -0.49 |
| Stochastic Oscillator | 35.34 | 42.99 |
Price Performance
Historical ComparisonAbout IRT Independence Realty Trust Inc.
Independence Realty Trust Inc is a real estate investment trust (REIT) that acquires, owns, operates, improves and manages multifamily apartment communities across non-gateway U.S. markets. It owns and operates multifamily apartment properties, across non-gateway U.S markets, including Louisville, Memphis, Atlanta, and Raleigh. The company is focused on gaining scale within key amenity-rich submarkets that offer school districts, retail, and various employment centers.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.